NEWS & EVENTS
Medoc follows scientific advancements using quantitative sensory testing closely. We share some of the recent publications regarding QST and Medoc’s devices here. We applaud our many customers for their scientific efforts in acquiring new insights in the field of neurology, basic science and pain physiology and highlight their insights on our blog.
Will your holiday party glass of wine eliminate your pain?
People living with HIV exhibit altered central pain processing
Pain goes through the stomach for veterans with Gulf War Illness
Are headaches common due to lacking conditioned pain modulation (CPM)?
Is polyneuropathy reversible?
Thermal quantitative sensory testing proves pre-clinically relevant in type 2 Diabetes
QST testing may detect subclinical neuropathy and hence, treatment may be adjusted in time.
QST identifies the better surgical skin graft technique
Something to be optimistic about for 2019!
New technology may change the diagnosis and management of diabetic neuropathy
Growing QST Presence in Pharma Clinical Trials
Thermal QST as a predictor for drug efficacy
Cold-evoked potentials: Expanding capabilities of Pathway Model CHEPS
The QST results of Q-Sense are comparable to the well-established TSA-II
Normative data for Contact Heat Evoked Potentials (CHEPS) provided by a multicenter study
Relationship between decline in peripheral nerve function and glycemic control in Diabetes type 1
Prediction of Oxaliplatin-induced neuropathy using pretreatment QST
Determining heat and mechanical pain threshold
Examining penile sensitivity in neonatally circumcised and intact men using QST
The Effect of Tapentadol and Morphine on Conditioned Pain Modulation in Healthy Volunteers